Gulam A. Manji

Also affiliated with Columbia University Irving Medical Center, New York Hospital Queens, Herbert Irving Comprehensive Cancer Center, Columbia University

Biochemistry, Genetics and Molecular BiologyMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Papers

Driven by 20 papers — median percentile 80. Top paper: “Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer”.

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Nature(2024)10.1038/s41586-024-07379-z

N/A

3.9DataRank · unranked

182 citations

Jingjing Jiang, Tanner C. Dalton, Álvaro Curiel‐García, A. Cole Edwards, Yingyun Wang +61 more

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

OncoImmunology(2022)10.1080/2162402x.2022.2066767

N/A

0.768DataRank · unranked

19 citations

Thomas Enzler, Pan Kim, Benjamin T. Fullerton, Ladan Fazlollahi, Andrew Chen +20 more

Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment

Trends in cancer(2021)10.1016/j.trecan.2021.04.008

N/A

0.661DataRank · unranked

81 citations

Yun Kyoung Ryu, Gulam A. Manji, Anil K. Rustgi, Anna M. Chiarella

A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0285

N/A

0.614DataRank · unranked

59 citations

Jarwei Fang, Martha Salas, Catherine Do, Emily Hsu, Anna Zhukovskaya +9 more

Pervasiveness of HLA allele-specific expression loss across tumor types

Genome Medicine(2023)10.1186/s13073-023-01154-x

N/A

0.470DataRank · unranked

22 citations

Anqi Wang, Oleksandr Valeriiovych Kravets, Rose Orenbuch, Junfei Zhao, Tomin E. Perea-Chamblee +6 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951

N/A

0.312DataRank · unranked

7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more

Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients

Cancer Reports(2022)10.1002/cnr2.1565

N/A

0.292DataRank · unranked

6 citations

Brianna N. Lauren, Yoanna S Pumpalova, Jiheum Park, Francesca Lim, Susan E. Bates +5 more

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status

ESMO Gastrointestinal Oncology(2024)10.1016/j.esmogo.2024.100042

N/A

0.208DataRank · unranked

3 citations

Yasmine Baca, Joanne Xiu, Phillip Walker, Gulam A. Manji, Sepideh Gholami +13 more

Cost-effectiveness of universal screening for germline BRCA mutations in metastatic pancreatic cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.536

N/A

0.104DataRank · unranked

1 citations

Yoanna S Pumpalova, Jiheum Park, Francesca Lim, Jennifer S. Ferris, Susan E. Bates +4 more

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.03.569791

N/A

0DataRank · unranked

11 citations

Jingjing Jiang, Alvaro Curiel-Garcia, Yingyun Wang, Bianca J. Lee, Margo Orlen +42 more

Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.19.533333

N/A

0DataRank · unranked

8 citations

Sam R. Holmstrom, Cristina Castillo, Carmine F. Palermo, Stephen A. Sastra, Anthony Andren +21 more

Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.24.573257

N/A

0DataRank · unranked

4 citations

Ilenia Pellicciotta, Carmine F. Palermo, Steven A. Sastra, Andrew Chen, Emily Alouani +7 more

HLA allele-specific expression loss in tumors can shorten survival and hinder immunotherapy

medRxiv(2020)10.1101/2020.09.30.20204875

N/A

0DataRank · unranked

4 citations

Rose Orenbuch, Junfei Zhao, Gulam A. Manji, Evangelina López de Maturana, Núria Malats +3 more

A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX

The Oncologist(2024)10.1093/oncolo/oyad315

N/A

0DataRank · unranked

4 citations

Michael May, Alexander G. Raufi, Lyndon Luk, Winston Wong, Prabhjot S. Mundi +2 more

A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery

The Oncologist(2025)10.1093/oncolo/oyaf162

N/A

0DataRank · unranked

3 citations

Valeria Mezzano-Robinson, Qiongyu Shi, Nadine Kuriakose, Beth Schrope, Michael D. Kluger +8 more

Cost-effectiveness analysis of platinum-based chemotherapy treatment options for germline BRCA-mutated locally advanced/borderline resectable pancreatic cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16246

N/A

0DataRank · unranked

0 citations

Yoanna S Pumpalova, Jiheum Park, Francesca Lim, Gulam A. Manji, Chung Yin Kong +2 more

Dose-finding designs for trials of molecularly targeted agents and immunotherapies

UNC Libraries(2020)10.17615/97xj-4d96

N/A

0DataRank · unranked

0 citations

Anastasia Ivanova, Jonathan Shtaynberger, Jimmy Duong, Gulam A. Manji, Chiuzan, Cody +2 more

Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in locally advanced/borderline resectable pancreatic cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16793

N/A

0DataRank · unranked

0 citations

Brianna N. Lauren, Yoanna S Pumpalova, Gulam A. Manji, Susan E. Bates, Chin Hur +1 more

Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer

Cancer Investigation(2023)10.1080/07357907.2023.2203747

N/A

0DataRank · unranked

4 citations

Jacob K. Jamison, Winston Wong, Alissa Michel, Alexander G. Raufi, Alfred I. Neugut +2 more

Gulam A. Manji

Indexed papers

Top data-sharing exemplar

Papers